HRTX Heron Therapeutics

Watchlist

2.710
-0.060-2.17%

Close Apr 18 16:00 ET

2.680
-0.030-1.11%

Post 19:46 ET

407.39MMarket Cap-3387P/E (TTM)

About Heron Therapeutics Company

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Company Profile

SymbolHRTX

Company NameHeron Therapeutics

Listing DateJan 23, 2014

Issue Price7.00

Founded1983

CEOMr. Craig A. Collard

MarketNASDAQ

Employees126

Securities TypeOrdinary Shares

Fiscal Year Ends12-31

Address4242 Campus Point Court,Suite 200

CitySan Diego

ProvinceCalifornia

CountryUnited States of America

Zip Code92121

Phone1-858-251-4400

Websitehttp://www.herontx.com

Company Executives

Name
Position
Salary

Craig A. Collard
Director and Chief Executive Officer
--

Ira Duarte
Executive Vice President and Chief Financial Officer
--

Dr. William P. Forbes
Executive Vice President and Chief Development Officer
--

Dr. Thomas B. Ottoboni
Chief Scientific Officer and Senior Vice President, Pharmaceutical and Translational Sciences
--

Chris Storgard, M.D.
Chief Medical Officer
--

Robert Sullivan
Senior Vice President, Oncology Care Franchise and Commercial Operations
--

Jason Grillot
Vice President, Sales and Marketing, Acute Care
--

Sean T. Ristine
Senior Vice President, Human Resources
--

Laura Singer
Vice President, Quality Assurance
--

Dr. John C. Arthur, PhD
Vice President, Manufacturing and Supply
--

Adam Morgan
Chairman of the Board
--

Christian Waage
Independent Director
309.23K

Dr. Sharmila Dissanaike, F.A.C.S.,M.D.
Independent Director
285.31K

Craig A. Johnson
Lead Independent Director
339.23K

Susan Rodriguez
Independent Director
288.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall